IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v16y2015i1p65-72.html
   My bibliography  Save this article

Cost of poor adherence to anti-hypertensive therapy in five European countries

Author

Listed:
  • F. Mennini
  • A. Marcellusi
  • J. Schulenburg
  • A. Gray
  • P. Levy
  • P. Sciattella
  • M. Soro
  • G. Staffiero
  • J. Zeidler
  • A. Maggioni
  • R. Schmieder

Abstract

The financial burden for EU health systems associated with cardiovascular disease (CV) has been estimated to be nearly €110 billion in 2006, corresponding to 10 % of total healthcare expenditure across EU or a mean €223 annual cost per capita. The main purpose of this study is to estimate the costs related to hypertension and the economic impact of increasing adherence to anti-hypertensive therapy in five European countries (Italy, Germany, France, Spain and England). A probabilistic prevalence-based decision tree model was developed to estimate the direct costs of CV related to hypertension (CV defined as: stroke, heart attack, heart failure) in five European countries. Our model considered adherence to hypertension treatment as a main driver of blood pressure (BP) control (BP > 140/90 mmHg). Relative risk of CV, based on controlled or uncontrolled BP group, was estimated from the Framingham Heart Study and national review data. Prevalence and cost data were estimated from national literature reviews. A national payer (NP) perspective for 10 years was considered. Probabilistic sensitivity analysis was performed in order to evaluate uncertainty around the results (given as 95 % confidence intervals). The model estimated a total of 8.6 million (1.4 in Italy, 3.3 in Germany, 1.2 in Spain, 1.8 in France and 0.9 in England) CV events related to hypertension over the 10-year time horizon. Increasing the adherence rate to anti-hypertensive therapy to 70 % (baseline value is different for each country) would lead to 82,235 fewer CV events (24,058 in Italy, 7,870 in Germany, 18,870 in Spain, 24,855 in France and 6,553 in England). From the NP perspective, the direct cost associated with hypertension was estimated to be €51.3 billion (8.1 in Italy, 17.1 in Germany, 12.2 in Spain, 8.8 in France and 5.0 in England). Increasing adherence to anti-hypertensive therapy to 70 % would save a total of €332 million (CI 95 %: €319–346 million) from the NPs perspective. This study is the first attempt to estimate the economic impact of non-adherence amongst patients with diagnosed hypertension in Europe, using data from five European countries (Italy, France, Germany, Spain and England). Copyright Springer-Verlag Berlin Heidelberg 2015

Suggested Citation

  • F. Mennini & A. Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder, 2015. "Cost of poor adherence to anti-hypertensive therapy in five European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(1), pages 65-72, January.
    • Handle: RePEc:spr:eujhec:v:16:y:2015:i:1:p:65-72
    DOI: 10.1007/s10198-013-0554-4
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s10198-013-0554-4
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s10198-013-0554-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to look for a different version below or search for a different version of it.

    Other versions of this item:

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zijing Pan & Wanchun Xu & Zhong Li & Chengzhong Xu & Fangfang Lu & Pei Zhang & Liang Zhang & Ting Ye, 2020. "Trajectories of Outpatient Service Utilisation of Hypertensive Patients in Tertiary Hospitals in China," IJERPH, MDPI, vol. 17(3), pages 1-15, January.
    2. Maria Teresa Greco & Antonio Giampiero Russo, 2017. "Valutazione del modello CREG utilizzato dalla ATS della Citt? Metropolitana di Milano per la gestione delle malattie croniche nella medicina generale," MECOSAN, FrancoAngeli Editore, vol. 2017(101), pages 31-50.
    3. Klaus Mann & Michael Möcker & Joachim Grosser, 2019. "Adherence to long-term prophylactic treatment: microeconomic analysis of patients’ behavior and the impact of financial incentives," Health Economics Review, Springer, vol. 9(1), pages 1-10, December.

    More about this item

    Keywords

    Economic burden; Hypertension; Hypertensive therapy; Cost of illness; Adherence; H00 General public health;
    All these keywords.

    JEL classification:

    • H00 - Public Economics - - General - - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:16:y:2015:i:1:p:65-72. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.